While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...
Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Moderna in a note issued to investors ...
Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...
The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme ...
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...
Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...
US stocks saw a decline on Monday as investors continued to unload key tech shares that have been driving the bull market.
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says.